148 related articles for article (PubMed ID: 18498351)
1. Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli.
Kouzmenko AP; Takeyama K; Kawasaki Y; Akiyama T; Kato S
Genes Cells; 2008 Jul; 13(7):723-30. PubMed ID: 18498351
[TBL] [Abstract][Full Text] [Related]
2. Truncation mutations abolish chromatin-associated activities of adenomatous polyposis coli.
Kouzmenko AP; Takeyama K; Kawasaki Y; Akiyama T; Kato S
Oncogene; 2008 Aug; 27(36):4888-99. PubMed ID: 18454178
[TBL] [Abstract][Full Text] [Related]
3. Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types.
Min G
Ann N Y Acad Sci; 2006 Dec; 1091():244-57. PubMed ID: 17341619
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.
Gerner EW; Ignatenko NA; Lance P; Hurley LH
Ann N Y Acad Sci; 2005 Nov; 1059():97-105. PubMed ID: 16382048
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells.
Bhattacharya G; Boman BM
Biochem Biophys Res Commun; 1995 Mar; 208(1):103-10. PubMed ID: 7887918
[TBL] [Abstract][Full Text] [Related]
8. Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability.
Tighe A; Johnson VL; Taylor SS
J Cell Sci; 2004 Dec; 117(Pt 26):6339-53. PubMed ID: 15561772
[TBL] [Abstract][Full Text] [Related]
9. Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.
Kurzik-Dumke U; Hörner M; Czaja J; Nicotra MR; Simiantonaki N; Koslowski M; Natali PG
Int J Mol Med; 2008 Jan; 21(1):19-31. PubMed ID: 18097612
[TBL] [Abstract][Full Text] [Related]
10. Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours.
Kohler EM; Derungs A; Daum G; Behrens J; Schneikert J
Hum Mol Genet; 2008 Jul; 17(13):1978-87. PubMed ID: 18387968
[TBL] [Abstract][Full Text] [Related]
11. ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells.
Chen M; Ni J; Zhang Y; Muyan M; Yeh S
Prostate; 2008 Sep; 68(12):1273-82. PubMed ID: 18563714
[TBL] [Abstract][Full Text] [Related]
12. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
13. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants.
Kato N; Shibuya H; Fukase M; Tamura G; Motoyama T
Hum Pathol; 2006 Jan; 37(1):48-53. PubMed ID: 16360415
[TBL] [Abstract][Full Text] [Related]
14. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.
Dundar M; Caglayan AO; Saatci C; Karaca H; Baskol M; Tahiri S; Ozkul Y
Cancer Genet Cytogenet; 2007 Sep; 177(2):95-7. PubMed ID: 17854661
[TBL] [Abstract][Full Text] [Related]
15. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation.
Abal M; Obrador-Hevia A; Janssen KP; Casadome L; Menendez M; Carpentier S; Barillot E; Wagner M; Ansorge W; Moeslein G; Fsihi H; Bezrookove V; Reventos J; Louvard D; Capella G; Robine S
Gastroenterology; 2007 Jun; 132(7):2448-58. PubMed ID: 17570218
[TBL] [Abstract][Full Text] [Related]
16. Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.
Kucherlapati M; Nguyen A; Kuraguchi M; Yang K; Fan K; Bronson R; Wei K; Lipkin M; Edelmann W; Kucherlapati R
Oncogene; 2007 Sep; 26(43):6297-306. PubMed ID: 17452984
[TBL] [Abstract][Full Text] [Related]
17. [Promoter hypermethylation and loss of heterozygosity of the APC gene in patients with familial adenomatous polyposis].
Zhang YY; Chen SQ; Zhu M; Li JT; Ma GJ; Zhang XM; Zhou JN
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):378-81. PubMed ID: 18683131
[TBL] [Abstract][Full Text] [Related]
18. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated NH2-terminal fragments are the most stable part of the adenomatous polyposis coli protein and can be regulated by interactions with COOH-terminal domains.
Li Z; Näthke IS
Cancer Res; 2005 Jun; 65(12):5195-204. PubMed ID: 15958564
[TBL] [Abstract][Full Text] [Related]
20. Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells.
Potier M; Tran TA; Chantome A; Girault A; Joulin V; Bougnoux P; Vandier C; Pierre F
Biochem Biophys Res Commun; 2010 Jun; 397(1):42-7. PubMed ID: 20519134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
